Submission of voting results.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (BSE: 536565) held its 31st AGM on September 19, 2025, via video conferencing, where 9 resolutions were put to vote. All 9 resolutions were passed with overwhelming shareholder approval, receiving approximately 99.9999% of votes in favor. The total number of shareholders on record date was 2,776, with about 77.53% of outstanding shares participating in the voting (except for Resolution 9 where promoter interest reduced participation to 74.83%). Key resolutions included adoption of FY25 audited financial statements, re-appointment of a director, appointment of Secretarial Auditors, increasing borrowing limits under Section 180(1)(c), creation of mortgage/charge on assets, approvals for investments/loans/guarantees under Sections 185 and 186, and appointment of new directors including Ms. Mayuri Baidya as Independent Director and Mr. Gattu Gnana Prakash as Non-Executive Director.
All resolutions passed with near-unanimous support, indicating strong shareholder confidence. The increased borrowing limits and ability to give loans, guarantees, and create charges on company assets (Resolutions 4-7) give the company greater financial flexibility for future expansion or debt-raising activities. These are routine governance approvals with no immediate price-moving impact, but they position the company for potential capital-raising or strategic moves.